Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
245.4 CHF | +0.68% |
|
-1.57% | +0.04% |
09:15am | Roche: CE marking in diabetes monitoring | CF |
07:43am | Roche Secures CE Mark for AI-powered Continuous Glucose Monitoring Device | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.04% | 219B | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.21% | 240B | |
+14.68% | 221B | |
+8.14% | 167B | |
-2.99% | 158B | |
+3.38% | 125B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche Secures FDA Nod to Relaunch Susvimo in US After Recall